Russian Countersanctions – Are Your Stocks at Risk?

Western sanctions and Russian countersanctions are creating an economic crossfire. What companies are caught in the middle? More 

Despite Multiple Headwinds, Pfizer Stock Is Worth a Long Look

After a failed AstraZeneca (AZN) acquisition, Pfizer (PFE) must look elsewhere for growth. More 

Why the Traditional IRA Is Dead

Traditional IRAs may not provide the expected tax-deferral benefits. Find out where conventional wisdom gets retirement savings wrong. More 

Google Images Bug: Results Replaced With Russian Car Crash Photo

Many users trying to do a Google Image search on Tuesday morning reported seeing repeating images of a Russian car crash. More 

New Fall TV Shows 2014: 5 Series to Watch

As autumn approaches, it's time to look at some of the best new fall TV shows to watch for this year including 'Gotham.' More 

FB News: Facebook to Clamp Down on ‘Clickbait’

Facebook, announced on Monday, that it's making efforts to reduce the amount of 'clickbait' that appears in users' News Feeds. More 

This Unique Dividend ETF Is Quietly Killing the Competition

The Global X Super Dividend U.S. ETF (DIV) is an intriguing income holding now, and over time, the dividend ETF could be worthy of a core portfolio slot. More